1. Home
  2. News & Events
  3. News & Events

News & Events

GW Pharmaceuticals Reports Positive Phase 3 Pivotal Trial Results for EPIDIOLEX® (cannabidiol) Oral Solution in Patients with Seizures Associated With Tuberous Sclerosis Complex
- Achieved primary efficacy measure with both EPIDIOLEX doses as compared to placebo - - Represents the fifth consecutive positive Phase 3 pivotal trial for EPIDIOLEX - - Expect to file sNDA in Q4 2019 -   Carlsbad, CA, May 6, 2019: GW Pharmaceuticals plc and its U.S. subsidiary Greenwich Biosciences Inc. (NASDAQ: GWPH, GW, the Company or the Group), the world leader in the scien...
Read more
Medicinal Cannabis: Positive results in treatment of children with seizures from Tuberous Sclerosis Complex (TSC)
Medicinal Cannabis
Medicinal Cannabis: Positive results in treatment of children with seizures from Tuberous Sclerosis Complex (TSC) A phase 3 clinical trial has shown that the cannabis-based medicine Epidiolex ® (cannabidiol oral solution or CBD) manufactured and supplied by GW pharmaceuticals was successful in the treatment of seizures associated with Tuberous Sclerosis Complex (TSC). TSC is a rare genetic...
Read more
Cannabis-based medicine eases seizures in Dravet syndrome
Medicinal cannabis
A phase III clinical trial has shown the cannabis-based medicine Epidiolex® (cannabidiol oral solution) to reduce seizures in children with Dravet syndrome, a rare and severe form of childhood-onset epilepsy.  Sydney Children’s Hospital, Randwick, was one of two sites in Australia to take part in the international study, which reinforced the safety and efficacy of the drug in reducing sei...
Read more
Medicinal Cannabis: safe for children with severe epilepsy
Medicinal Cannabis
Findings into the safety of Epidiolex®, an experimental cannabis-based treatment for severe drug-resistant epilepsy in children, have been published in the Medical Journal of Australia. Under the NSW Government funded Compassionate Access Scheme, children with the most severe forms of childhood epilepsy, who are too sick to participate in a clinical trial, have an opportunity to access a canna...
Read more

Addresses

Cnr Hawkesbury Rd & Hainsworth St
Westmead, NSW 2145, Australia

Bright Alliance, Level 8
Cnr Avoca & High St
Randwick, NSW 2031, Australia

General Enquires

T: +61 2 9845 1400
F: +61 2 9845 1317
E: schn-research@health.nsw.gov.au

The Sydney Children's Hospitals Network

Partners

Children's Medical Research Institute
Luminesce Alliance
The Westmead Institute
University of Sydney
UNSW Sydney

The Sydney Children's Hospitals Network

Address

Cnr Hawkesbury Rd & Hainsworth St
Westmead, NSW 2145, Australia

Bright Alliance, Level 8
Cnr Avoca & High St
Randwick, NSW 2031, Australia

General Enquires

T: +61 2 9845 1400
F: +61 2 9845 1317
E: schn-research@health.nsw.gov.au

Partners

Children's Medical Research Institute
Luminesce Alliance
The Westmead Institute
University of Sydney
UNSW Sydney